Navigation Links
US Senate Passes Stem Cell Research Bill

The US Senate has passed a bill that aims to loosen President George Bush's restrictions on human embryonic stem cell research for the second time// in nine months, but has once again fallen short of the 67 votes needed to override a promised veto, media reports said.

The Senate voted 63 to 34 to pass the Stem Cell Research Enhancement Act, which would allow federally funded studies of stem cells isolated from embryos slated for destruction at fertility clinics, the Washington Post reported Wednesday.

The vote capped 20 hours of often passionate debate, with proponents focusing on the cells' potential to help treat a wide range of diseases and opponents decrying the fact that human embryos must be destroyed to retrieve them.

With the House having passed a similar bill in January, the two chambers are now set to hammer out compromise wording and send the legislation to Bush. But the White House Tuesday set the stage for a new Bush veto, saying it was unthinkable that public tax money should be used to destroy human embryos.

Bush used his power of veto for the first time in his presidency to slap down a similar text passed in Congress last year, when it was then controlled by his Republican party.

However, proponents are relishing the fact that they will have the opportunity to rebuke the president by overriding that veto this time.

Although the House majority favouring the legislation is 15 votes larger this year than that in 2005, it is still dozens short of the two-thirds needed for an override.

In that case, Bush's veto pen will prevail and the situation will revert to what it has been since Aug 9, 2001 -- when Bush, in his first major televised address to the nation, declared that federal funds could only be used to study stem cells derived from embryos already destroyed by that date.

Source-IANS/B
'"/>




Page: 1

Related medicine news :

1. Senate assures ban on smoking
2. US Senate Votes against Testing of Pesticide on Humans
3. US Senate Approves Embryo-research Plan Despite Presidents Refusal
4. Senate Committee Approves Telemedicine Mental Health Bill
5. Organ Donation Crusader Passes Away
6. A Mother Passes On A Rare, Terminal Brain Disease To Her Three Children
7. Renowned Doctor Passes Away
8. Founder of Enron, Ken Lay Passes Away
9. Maoist Leader-Turned Social Activist Passes Away
10. Jeff Getty, AIDS Activist, Passes Away
11. WHO Passes Rotavirus Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... In response to meager public ... unaware of the plight of aphasia. In collaboration with the American Aphasia Association, ... , The link between stroke and aphasia is relatively unknown, but through collaboration ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in the health ... of leaders in the nursing and health care industry. It also provides insight to ... Christian University. , As the nursing industry is coming out of one of ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media ... Janet Yellen and company to wait until March 2017 for an interest rate increase, ... Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to ... Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final ... and levels of the game, Connor Sports has committed to a significantly increased focus ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 Inivata, ... precision of circulating tumour DNA (ctDNA) analysis to ... appointment of Professor Clive Morris as ... across the clinical development programme, scientific collaborations, and ... deliver significant improvements in clinical outcomes for patients. ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... Mass. , May 24, 2016  NxStage Medical, ... technology company focused on advancing renal care, today announced ... plans to participate in the following schedule of investor ... be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, June ...
Breaking Medicine Technology: